 |
인쇄하기
취소
|
Binex to export Remicade biosimilar to Russia
Binex said Thursday it will export Remicade biosimilar to Pharmstandard, Russia’s leading drugmaker.
Developed by Johnson & Johnson, Remicade is a blockbuster rheumatoid arthritis drug.
The Korean pharmaceutical firm and Pharmstandard had signed a contract to export the biosimilar to treat arthritis.
Binex’s biosimilar export deal will pave the way for more medical exports to the Europ...
Developed by Johnson & Johnson, Remicade is a blockbuster rheumatoid arthritis drug.
The Korean pharmaceutical firm and Pharmstandard had signed a contract to export the biosimilar to treat arthritis.
Binex’s biosimilar export deal will pave the way for more medical exports to the Europ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.